In key en­dorse­ment, Deer­field re­serves $65M for drug ven­ture with UNC-Chapel Hill

Last Oc­to­ber, Deer­field Man­age­ment teamed up with the Broad In­sti­tute of MIT and Har­vard for a nov­el ap­proach to pur­su­ing trans­la­tion­al re­search. Just over a year lat­er, the mar­quee health­care in­vest­ment firm is look­ing be­yond the heart of the Boston/Cam­bridge biotech hub for its next deal.

With $65 mil­lion in tar­get­ed fund­ing, Deer­field is com­mit­ting to bankroll and sup­port drug re­search com­ing out of the Uni­ver­si­ty of North Car­oli­na, Chapel Hill, through a new com­pa­ny.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.